EMVision Medical Devices secures strategic deal to advance brain scan technology

EMVision Medical Devices (ASX: EMV) executive director and co-founder Scott Kirkland joins Small Caps to discuss the latest developments on the path to commercialising the company’s brain scan technology.

EMVision has developed a portable medical scanning device that uses electromagnetic microwave imaging to diagnose and monitor stroke and other medical applications.

The company has been in collaboration with New York-listed Keysight Technologies for the past three years to develop a personalised and miniaturised healthcare-focused vector network analyser (VNA) solution for the sensors used inside its scanning device.

The pair have now inked an original equipment manufacturer agreement which provides EMVision with exclusive supply of the ‘fast sweep’ VNA for an initial 12-month term.

The deal is expected to give EMVision a substantial competitive advantage by enabling real-time diagnosis in limited space emergency medical environments such as ICUs and potentially ambulances.

EMVision is also backed by a $6.8 million grant from the Australian Stroke Alliance, of which newly appointed clinical advisory board members Professor Geoffrey Donnan and Professor Stephen Davis are co-chairs.

Articles:
https://smallcaps.com.au/emvision-medical-devices-vna-supply-deal-keysight-technologies/
https://smallcaps.com.au/emvision-ground-breaking-product-developments-continue-cash-reserves-rise/

For more information on EMVision Medical Devices:
https://smallcaps.com.au/stocks/EMV/

-----------------------

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

-----------------------

WEBSITE
https://smallcaps.com.au/

PODCAST
https://smallcaps.com.au/podcast/

SOCIAL MEDIA
Facebook: https://www.facebook.com/SmallCapsASX
Twitter: https://twitter.com/SmallCapsASX
LinkedIn: https://www.linkedin.com/company/small-caps/

NEWSLETTER
https://smallcaps.com.au/subscribe/